AMPH
Amphastar Pharmaceuticals, Inc.
24.30$
-0.7%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10.0% | 4.2% | 15.1% | 16.3% | 13.0% | 13.0% | 16.4% | 22.4% | 17.9% | 28.5% | 29.2% | 21.7% | |
| 6.9% | 5.3% | 5.7% | 6.4% | 5.6% | 6.6% | 7.2% | 6.1% | 5.8% | 6.5% | 7.8% | 8.8% | |
| 4.4% | 5.1% | 5.9% | 7.1% | 5.7% | 5.4% | 5.9% | 4.3% | 3.6% | 3.1% | 3.3% | 3.8% | |
| 0.0% | 1.6% | 5.0% | 7.8% | 5.7% | 7.1% | 5.9% | 1.8% | 0.5% | – | – | – | |
| 7.4% | -2.0% | 0.1% | 0.2% | 4.1% | -16.1% | 2.6% | -0.4% | -6.4% | -3.8% | -2.0% | -9.2% | |
| 9.7% | 6.4% | 8.4% | 14.6% | 15.9% | 12.9% | 9.7% | 6.3% | 4.8% | 5.9% | 5.6% | 4.8% | |
| -18.9% | -6.7% | -15.5% | -16.1% | -14.3% | -15.7% | -10.4% | -6.5% | -6.6% | -100.7% | -17.1% | -9.8% | |
| 24.7% | 8.1% | 4.0% | 0.0% | 6.9% | – | 6.6% | 3.6% | 3.1% | 70.5% | – | – | |
| -0.3% | -3.9% | -3.9% | -12.8% | -8.5% | -6.9% | -7.0% | -6.6% | -8.0% | -9.0% | -11.7% | -10.5% | |
| 11.9% | -0.9% | -1.7% | 3.9% | 1.0% | -1.0% | -0.3% | 6.9% | -0.4% | 81.7% | 1.4% | 0.8% | |
| 15.3% | 0.9% | 2.8% | -3.2% | 8.5% | -1.2% | -0.6% | -8.5% | -5.3% | 70.5% | -11.1% | -9.4% | |
| 6.8% | -0.7% | 2.5% | -2.8% | 7.0% | -3.9% | 5.4% | 7.3% | 6.0% | -1.8% | 1.0% | 2.6% | |
| 0.3% | -2.1% | 6.7% | 1.7% | -2.9% | 0.1% | 6.7% | 16.1% | 13.1% | 22.6% | 23.5% | 16.8% |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.